Back to Journals » Drug Design, Development and Therapy » Volume 12

Abemaciclib: a CDK4/6 inhibitor for the treatment of HR+/HER2– advanced breast cancer

Total article views   Abstract views HTML views PDF downloads Totals
16,503 Dovepress* 7,714 3,578+ 1,609 11,292
PubMed Central* 0 5,211 991 5,211
Totals 7,714 8,789 2,600 16,503
*Since 16 February 2018
+Since July 2016

View citations on PubMed Central and Google Scholar